Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol
2. Lusefi
3. Ts 071
4. Ts-071
5. Ts071 Cpd
1. 898537-18-3
2. Luseogliflozin [inn]
3. Ts-071
4. Ts-71
5. C596hwf74z
6. Chembl1093423
7. Lusefi
8. (2s,3r,4r,5s,6r)-2-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2h-thiopyran-3,4,5-triol
9. (2s,3r,4r,5s,6r)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol
10. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-, (1s)-
11. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-, (1s)-
12. Ts 071
13. Unii-c596hwf74z
14. (2s,3r,4r,5s,6r)-2-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)thiane-3,4,5-triol
15. Ts71
16. Ts071 Cpd
17. Luseogliflozin [mi]
18. Schembl1487519
19. Luseogliflozin [who-dd]
20. Dtxsid10237921
21. Chebi:134725
22. Ts071
23. Bdbm50315426
24. Akos027326750
25. Db12214
26. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-, (1s)
27. A13476
28. Q27275212
29. (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol
Molecular Weight | 434.5 g/mol |
---|---|
Molecular Formula | C23H30O6S |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 125 |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 514 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A10 - Drugs used in diabetes
A10B - Blood glucose lowering drugs, excl. insulins
A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors
A10BK07 - Luseogliflozin
Market Place
ABOUT THIS PAGE
69
PharmaCompass offers a list of Luseogliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Luseogliflozin manufacturer or Luseogliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Luseogliflozin manufacturer or Luseogliflozin supplier.
PharmaCompass also assists you with knowing the Luseogliflozin API Price utilized in the formulation of products. Luseogliflozin API Price is not always fixed or binding as the Luseogliflozin Price is obtained through a variety of data sources. The Luseogliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Luseogliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Luseogliflozin, including repackagers and relabelers. The FDA regulates Luseogliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Luseogliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Luseogliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Luseogliflozin supplier is an individual or a company that provides Luseogliflozin active pharmaceutical ingredient (API) or Luseogliflozin finished formulations upon request. The Luseogliflozin suppliers may include Luseogliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Luseogliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Luseogliflozin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Luseogliflozin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Luseogliflozin GMP manufacturer or Luseogliflozin GMP API supplier for your needs.
A Luseogliflozin CoA (Certificate of Analysis) is a formal document that attests to Luseogliflozin's compliance with Luseogliflozin specifications and serves as a tool for batch-level quality control.
Luseogliflozin CoA mostly includes findings from lab analyses of a specific batch. For each Luseogliflozin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Luseogliflozin may be tested according to a variety of international standards, such as European Pharmacopoeia (Luseogliflozin EP), Luseogliflozin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Luseogliflozin USP).